Phase 2 Trial Posted on 31st October 202331st October 2023 Combination treatment with avelumab and regorafenib has shown activity in patients with relapsed/refractory gastrointestinal stromal tumors (GIST), according to research presented at the ESMO Congress 2023. Posted in GIST News.